Is a complete LGVN research report available?

No complete published report is available for Longeveron Inc. (LGVN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Longeveron Inc. (LGVN)

NASDAQ: LGVN · USD

$1.76

+0.03 (+1.7%)· Recorded snapshot

Market cap	5.6M
Revenue (ttm)	1.2M
Net income (ttm)	-23.5M
EPS (ttm)	-$9.73
Shares out	3.2M
Volume	75,705
Beta	-0.20

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2M
Net income (ttm): -23.5M
EPS (ttm): -$9.73
Market cap: 5.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001721484
Company name	Longeveron Inc.
Country	United States
Country code	US
CUSIP number	54303L302
Earnings date	2026-11-10
Earnings time	amc
Employees	38
Employees change	12
Employees growth	46.15%
Enterprise value	$-3.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
Industry	Biotechnology
IPO date	2021-02-12
Is primary listing	Yes
Is SPAC	No
ISIN number	US54303L3024
Last 10-K release date	2026-03-17
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2026-08-27
Last stock split type	Reverse
Market cap	$5.6M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	No
Price	$1.76
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	LGVN
U.S. state	Florida
Website	https://longeveron.com

Metric

Value

Amount currency

USD

CIK code

0001721484

Company name

Longeveron Inc.

Country

United States

Country code

CUSIP number

54303L302

Earnings date

2026-11-10

Earnings time

amc

Employees

Employees change

Employees growth

46.15%

Enterprise value

$-3.9M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

Industry

Biotechnology

IPO date

2021-02-12

Is primary listing

Yes

Is SPAC

ISIN number

US54303L3024

Last 10-K release date

2026-03-17

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split date

2026-08-27

Last stock split type

Reverse

Market cap

$5.6M

Market cap category

Nano-Cap

Next earnings date

2026-11-10

Options

Price

$1.76

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

LGVN

U.S. state

Florida

Website

https://longeveron.com

Metric	Value
Earnings yield	-552.61%
FCF / EV yield	524.27%
FCF yield	-368.04%
Forward P/S	2.71x
P/B ratio	0.53x
P/S ratio	4.7x
Price / tangible book value	0.68x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-552.61%

FCF / EV yield

524.27%

FCF yield

-368.04%

Forward P/S

2.71x

P/B ratio

0.53x

P/S ratio

4.7x

Price / tangible book value

0.68x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	69.76%
Operating margin	-1,975.99%
Pretax margin	-1,977.59%
Profit per employee	$-617,737
Revenue per employee	$31,237
ROA	-90.95%
ROA (5Y)	-55.21%
ROCE	-209.79%
ROE	-203.61%
ROE (5Y)	-117.01%
ROIC	-118.32%
SBC / revenue	132.77%

Metric

Value

Gross margin

69.76%

Operating margin

-1,975.99%

Pretax margin

-1,977.59%

Profit per employee

$-617,737

Revenue per employee

$31,237

ROA

-90.95%

ROA (5Y)

-55.21%

ROCE

-209.79%

ROE

-203.61%

ROE (5Y)

-117.01%

ROIC

-118.32%

SBC / revenue

132.77%

Metric	Value
EPS growth quarters	2
EPS growth years	2
Gross profit growth	-49.26%
Gross profit growth (Q)	24.66%
Gross profit growth 3Y	59%
Gross profit growth 5Y	-8.04%
Net income growth years	1
Revenue growth	-42.74%
Revenue growth (Q)	-9.18%
Revenue growth (QoQ)	-27.89%
Revenue growth 3Y	10.41%
Revenue growth 5Y	-21.21%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-49.26%

Gross profit growth (Q)

24.66%

Gross profit growth 3Y

59%

Gross profit growth 5Y

-8.04%

Net income growth years

Revenue growth

-42.74%

Revenue growth (Q)

-9.18%

Revenue growth (QoQ)

-27.89%

Revenue growth 3Y

10.41%

Revenue growth 5Y

-21.21%

Revenue growth years

Metric	Value
Capital expenditures	$-160,000
Depreciation and amortization	$1M
EBIT	$-23.5M
EBITDA	$-22.4M
EPS	$-9.73
FCF per share	$-6.44
Financing cash flow	$20.4M
Free cash flow	$-20.5M
Free cash flow minus SBC	$-22.1M
Gross profit	$828,000
Investing cash flow	$-305,000
Net cash flow	$-257,000
Net income	$-23.5M
Operating cash flow minus SBC	$-22M
Operating income	$-23.5M
Revenue	$1.2M
Stock-based compensation	$1.6M

Metric

Value

Capital expenditures

$-160,000

Depreciation and amortization

$1M

EBIT

$-23.5M

EBITDA

$-22.4M

EPS

$-9.73

FCF per share

$-6.44

Financing cash flow

$20.4M

Free cash flow

$-20.5M

Free cash flow minus SBC

$-22.1M

Gross profit

$828,000

Investing cash flow

$-305,000

Net cash flow

$-257,000

Net income

$-23.5M

Operating cash flow minus SBC

$-22M

Operating income

$-23.5M

Revenue

$1.2M

Stock-based compensation

$1.6M

Metric	Value
Altman Z-Score	-15.13
Book value per share	$3.28
Debt / equity	0.06
Long-term assets	$4.2M
Long-term liabilities	$778,000
Net cash (debt)	$9.5M
Net cash / market cap	170.2%
Net cash growth	3.28%
Net debt / equity	-0.91
Piotroski F-Score	1
Property, plant and equipment	$2M
Shareholders' equity	$10.4M
Tangible book value	$8.2M
Tangible book value per share	$2.59
Total assets	$15.5M
Total cash	$10.1M
Total debt	$581,000
Total liabilities	$5.1M
WACC	2.85%

Metric

Value

Altman Z-Score

-15.13

Book value per share

$3.28

Debt / equity

0.06

Long-term assets

$4.2M

Long-term liabilities

$778,000

Net cash (debt)

$9.5M

Net cash / market cap

170.2%

Net cash growth

3.28%

Net debt / equity

-0.91

Piotroski F-Score

Property, plant and equipment

$2M

Shareholders' equity

$10.4M

Tangible book value

$8.2M

Tangible book value per share

$2.59

Total assets

$15.5M

Total cash

$10.1M

Total debt

$581,000

Total liabilities

$5.1M

WACC

2.85%

Metric	Value
Asset turnover	0.07
Current assets	$11.3M
Current liabilities	$4.3M
Current ratio	2.63
Net working capital	$-2.5M
Quick ratio	2.35
Working capital	$7M
Working capital turnover	0.16

Metric

Value

Asset turnover

0.07

Current assets

$11.3M

Current liabilities

$4.3M

Current ratio

2.63

Net working capital

$-2.5M

Quick ratio

2.35

Working capital

$7M

Working capital turnover

0.16

Metric	Value
Buyback yield / dilution	-64.79%
Dividend yield	0%
Shareholder yield	-64.79%

Metric

Value

Buyback yield / dilution

-64.79%

Dividend yield

Shareholder yield

-64.79%

Metric	Value
150-day SMA	$6.76
1D price change	1.73%
1M price change	-37.37%
1M total return	-37.37%
1W price change	23.08%
1W total return	23.08%
1Y price change	-80.81%
1Y return CAGR	-80.83%
1Y total return	-80.81%
20-day SMA	$1.96
200-day SMA	$6.67
3M price change	-71.19%
3M total return	-71.19%
3Y price change	-99.05%
3Y return CAGR	-78.84%
3Y total return	-99.05%
50-day SMA	$4.16
50-day SMA vs 200-day SMA	50under200
52-week high	$12.30
52-week high date	2026-04-07
52-week low	$1.31
52-week low date	2026-10-19
5Y price change	-99.5%
5Y return CAGR	-65.29%
5Y total return	-99.5%
6M price change	-80.44%
6M total return	-80.44%
All-time high	$4,500.00
All-time high date	2021-11-24
All-time low	$1.31
All-time low date	2026-10-19
Average true range (ATR)	$0.29
Average volume	73.5K
Beta (1Y)	1.22
Beta (2Y)	1.11
Beta (5Y)	-0.2
Change from 52-week high	-85.69%
Change from 52-week low	34.35%
Change from all-time high	-99.96%
Change from all-time low	34.35%
Change from open	2.62%
Day's gap	-0.87%
Dollar volume	$133,241
High price	$1.78
Low price	$1.72
Monthly RSI	36.53
Open price	$1.72
Position in 52-week range	69.23%
Premarket change	2.02%
Premarket close	$1.73
Premarket price	$1.77
Previous close	$1.73
Price vs 150-day SMA	-73.95%
Price vs 20-day SMA	-10.07%
Price vs 200-day SMA	-73.63%
Price vs 50-day SMA	-57.7%
Relative volume	1.04
Return from IPO open	-99.83%
Return from IPO price	-82.5%
RSI	32.35
Sharpe ratio	-0.71
Sharpe ratio (3Y)	-0.45
Sharpe ratio (5Y)	0.06
Sortino ratio	-1
Sortino ratio (3Y)	-0.75
Sortino ratio (5Y)	0.19
Volume	75.7K
Weekly RSI	32.95
YTD price change	-65.22%
YTD total return	-65.22%

Metric

Value

150-day SMA

$6.76

1D price change

1.73%

1M price change

-37.37%

1M total return

-37.37%

1W price change

23.08%

1W total return

23.08%

1Y price change

-80.81%

1Y return CAGR

-80.83%

1Y total return

-80.81%

20-day SMA

$1.96

200-day SMA

$6.67

3M price change

-71.19%

3M total return

-71.19%

3Y price change

-99.05%

3Y return CAGR

-78.84%

3Y total return

-99.05%

50-day SMA

$4.16

50-day SMA vs 200-day SMA

50under200

52-week high

$12.30

52-week high date

2026-04-07

52-week low

$1.31

52-week low date

2026-10-19

5Y price change

-99.5%

5Y return CAGR

-65.29%

5Y total return

-99.5%

6M price change

-80.44%

6M total return

-80.44%

All-time high

$4,500.00

All-time high date

2021-11-24

All-time low

$1.31

All-time low date

2026-10-19

Average true range (ATR)

$0.29

Average volume

73.5K

Beta (1Y)

1.22

Beta (2Y)

1.11

Beta (5Y)

-0.2

Change from 52-week high

-85.69%

Change from 52-week low

34.35%

Change from all-time high

-99.96%

Change from all-time low

34.35%

Change from open

2.62%

Day's gap

-0.87%

Dollar volume

$133,241

High price

$1.78

Low price

$1.72

Monthly RSI

36.53

Open price

$1.72

Position in 52-week range

69.23%

Premarket change

2.02%

Premarket close

$1.73

Premarket price

$1.77

Previous close

$1.73

Price vs 150-day SMA

-73.95%

Price vs 20-day SMA

-10.07%

Price vs 200-day SMA

-73.63%

Price vs 50-day SMA

-57.7%

Relative volume

1.04

Return from IPO open

-99.83%

Return from IPO price

-82.5%

RSI

32.35

Sharpe ratio

-0.71

Sharpe ratio (3Y)

-0.45

Sharpe ratio (5Y)

0.06

Sortino ratio

-1

Sortino ratio (3Y)

-0.75

Sortino ratio (5Y)

0.19

Volume

75.7K

Weekly RSI

32.95

YTD price change

-65.22%

YTD total return

-65.22%

Metric	Value
Float	2.4M
Float percentage	73.95%
Shares change (QoQ)	26.59%
Shares change (YoY)	64.79%
Shares held by insiders	17.83%
Shares held by institutions	15.45%
Shares outstanding	3.2M
Short % of float	4.53%
Short % of shares	3.35%
Short ratio	0.6 days

Metric

Value

Float

2.4M

Float percentage

73.95%

Shares change (QoQ)

26.59%

Shares change (YoY)

64.79%

Shares held by insiders

17.83%

Shares held by institutions

15.45%

Shares outstanding

3.2M

Short % of float

4.53%

Short % of shares

3.35%

Short ratio

0.6 days

Longeveron Inc. (LGVN)

Price

Financial snapshot

Fair-value bridge

Latest news · LGVN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LGVN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LGVN

Frequently asked questions